Best Fit European Region Funds ETFs
U.S. News evaluated 41 European Region Funds ETFs and 9 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
| Best Fit Scorecard | |
|---|---|
| Costs | Typical |
| Tracking Error | Typical |
| Bid/Ask Ratio | Typical |
| Holdings Diversity | Excellent |
Fund Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&P Europe 350TM (the "underlying index"). The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the stocks of leading companies in the following countries: Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, the Netherlands, Norway, Portugal, Spain, Sweden, Switzerland and the United Kingdom.
Fund Snapshot Updated 05.16.2013
| Previous Close | $42.27 | Expense Ratio | 0.60% |
| YTD Return | 7.5% | Avg. 30-Day Volume | 325,088 |
| 1-Year Return | 32.9% | Market Cap | Loading... |
| Bid | $42.23 | Shares Outstanding | 29,900,000 |
| Ask | $42.25 | Dividends | $1.19 |
| Top 10 Holdings | |
|---|---|
| Nestle Sa (E:NESN) | 3.01% |
| Hsbc Holdings Plc (E:HSBA) | 2.81% |
| Novartis Ag (E:NOVN) | 2.73% |
| Roche Hldgs Ag (E:ROG) | 2.41% |
| Vodafone Group (E:VOD) | 1.99% |
| Bp (E:BP.) | 1.82% |
| Sanofi (E:SAN) | 1.76% |
| Glaxosmithkline (E:GSK) | 1.72% |
| Royal Dutch Shell (E:RDSA) | 1.68% |
| Total (E:FP) | 1.58% |
| % of Total Holdings | 21.50% |
